Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Cortical Neuromodulation Using a Brain-machine Interface to Treat Freezing of Gait in Parkinson's Disease.

NCT06642519 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT06642519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06642519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Cortical Neuromodulation Using a Brain-machine Interface to Treat Freezing of Gait in Parkinson's Disease.
Lead sponsor
University of Toronto
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 10, 2025
Completion date
July 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

freezing of gait symptoms in parkinson's disease, parkinson disease